ALSTOM SA: Alstom to supply 30 Coradia trains to SNCF

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
57
ALSTOM SA: Alstom to supply 30 Coradia trains to SNCF Mobilités, reinforcing the regional TET1 trains

                                                                                                       

A contract worth approximately €250 million Alstom to supply 30 Coradia trains to SNCF Mobilités, reinforcing the regional TET 1  trains

3 April 2016 - Alstom is to supply SNCF Mobilités with 30 trains from its Coradia platform, for an amount worth approximately €250 million 2 . The order was placed in the context of the renewal of the Corail trains on the Intercity lines. Delivery of the new trains is scheduled from September 2018 onwards.

These 30 new trains will benefit several routes: Paris - Amiens - Boulogne, services to Montluçon from Paris and Bourges, Clermont-Ferrand - Nîmes (Cévenol), Toulouse - Hendaye, as well as lines in the Nouvelle-Aquitaine region (Bordeaux - La Rochelle, Bordeaux - Limoges). They are in addition to the 34 Coradia Liner trains ordered in October 2013 for the Intercity lines, the first of which were delivered to SNCF Mobilités in November 2016.

  "The first Coradia Liner Intercity trains, which run at 160 km/h, were approved and delivered at the end of 2016 and placed into commercial service in February 2017. This additional order is excellent news and will ensure the workload of our Reichshoffen site for 2018," says Jean-Baptiste Eyméoud, President of Alstom in France.

The 30 new trains come in three layouts: 19 trains with main line comfort levels, including ten 110-metre dual-mode trains and nine 72-metre electric trains, and eleven 72-metre dual-mode trains with regional comfort levels. The trains will be able to accommodate 165 passengers in their short version or 300 passengers in their long version.

The trains meet the requirements of SNCF Mobilités perfectly in terms of performance, comfort and passenger services. They are accessible to all passengers and come with large bay windows and ambient interior lighting; on-board movement is more fluid and new reclining seats have been fitted with armrests equipped with electric sockets and coat hangers.

The trains also possess large doors and platforms to optimise circulation inside the train and passenger exchange in stations, therefore travel time. Traction is distributed throughout the train and energy consumption is lower compared to previous models. The train architecture has been specially designed for easy maintenance. The trains conform to current European standards and are capable of running on all tracks on the conventional network.

The trains belong to Alstom's Coradia range of modular trains, which benefits from over 30 years of expertise and proven technical solutions. More than 2,400 Coradia trains have been sold to date and 1,900 trains are currently in circulation in Denmark, France, Germany, Italy, Luxembourg, the Netherlands, Portugal, Spain, Sweden and Canada.

Six of the ten Alstom sites in France are involved in the design and manufacture of the Coradia trains: Reichshoffen for the design and assembly, Ornans for the engines, Le Creusot for the bogies, Tarbes for the traction systems, Villeurbanne for onboard electronics and Saint-Ouen for the design.

About Alstom As a promoter of sustainable mobility, Alstom develops and markets systems, equipment and services for the railway sector. Alstom manages the widest range of solutions in the market - from high-speed trains to metros and tramways - customised services (maintenance, modernisation,...) and infrastructure and signalling solutions. Alstom is a world leader in integrated railway systems. It recorded sales of €6.9 billion and booked €10.6 billion of orders in the 2015/16 fiscal year. Headquartered in France, Alstom is present in over 60 countries and employs 31,000 people today. Alstom's employees in France total approximately 8,800, providing a pool of expertise to serve French and international clients. A job at Alstom creates about three amongst its suppliers.   www.alstom.com

Press contacts Justine Rohée - Tel. + 33 1 57 06 18 81 justine.rohee@alstom.com Céline Grussenmeyer-Wolf - Tel. +33 3 88 90 04 40 celine.grussenmeyer-wolf@alstom.com

Investors relations Selma Bekhechi - Tél. + 33 1 57 06 95 39 Selma.bekhechi@alstom.com

Julien Minot - Tél. + 33 1 57 06 64 84 Julien.minot@alstom.com

[1] TET : Trains d'équilibre du territoire

[2] Booked in Q4 of 2016/17 fiscal year

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...6d81cec391

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Coke Florida's Commitment to Coastal Cleanliness Shines Bright

Updated Category News Views 141

Coke Florida's Volunteer Contributions for Coastal Cleanup Day Coca-Cola Beverages Florida, LLC (Coke Florida) was excited to take part in the worldwide celebration of International Coastal Cleanup (ICC) Day. This initiative, which focuses on sustainability and building community resilience, encouraged employees across the company's vast market to unite for a meaningful...

Continue Reading
LifeMD's Growth Momentum: Strong Earnings and Legal Support

Updated Category News Views 96

LifeMD Maintains Buy Rating Amid Positive Developments BTIG has reaffirmed its support for LifeMD Inc (NASDAQ: LFMD) by maintaining a Buy rating and a price target of $12.00 for the company’s stock. This endorsement comes at a pivotal time as the company experiences recent developments in the ongoing legal proceedings regarding tirzepatide, a drug used for treating type...

Continue Reading
Innovative Electric Heating Pad Adapter Set to Transform Comfort

Updated Category News Views 120

Innovative Heating Pad Adapter for Vehicles Inventors continuously strive to enhance daily experiences, and one such innovation is set to revolutionize comfort during travel. An inventor, inspired by the need for warmth while driving, developed the RIDE ALONG PRONG PLUG IN, a unique electric heating pad adapter accessible through a vehicle's cigarette lighter socket....

Continue Reading
Hang Feng Capital's Innovations Shine at Asia’s FinTech Hub

Updated Category News Views 158

Hang Feng Capital Excels at Hong Kong FinTech Week Recently, a remarkable event unfolded in the heart of Asia's financial landscape as Hang Feng Capital showcased its innovations during Hong Kong FinTech Week. Co-hosted by the local government and InvestHK, this pivotal event brought together over 700 exhibitors, 800 speakers, and an impressive crowd of 37,000 attendees...

Continue Reading
Autoliv Inc. Adjusts Revenue Forecast Amid Changing Market

Updated Category News Views 60

Autoliv Inc. got slapped with a serious reality check back in 2024 when JPMorgan revised its price target to $119, up just a hair from $117. You could feel the desks twitching as analysts dove into the automotive safety systems market, flagging Autoliv’s shaky standing amidst some forecasted storms brewing on the horizon. Global light vehicle production was supposed to...

Continue Reading